OUP Management »

Ikena Oncology shares owned by OUP Management

Quarter-by-quarter ownership of Ikena Oncology (IKNA) shares owned by OUP Management from 13F filings

Historical chart of OUP Management investment in Ikena Oncology

Tip: Access up to 7 years of quarterly data

All positions including Ikena Oncology held by OUP Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ikena Oncology by OUP Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $116k 27k 4.33

More positions owned by OUP Management

Centessa Pharmaceuticals Sponsored ADS (CNTA)
Aerovate Therapeutics Common Stock (AVTE)
Cyteir Therapeutics Common Stock
PMV Pharmaceuticals Common Stock (PMVP)
Graphite Bio Common Stock
Selecta Biosciences Common Stock (RNAC)
Vor Biopharma Common Stock (VOR)
eFFECTOR Therapeutics Common Stock
Precision BioSciences Common Stock
Spero Therapeutics Common Stock (SPRO)
Ikena Oncology Common Stock (IKNA)
Homology Medicines Common Stock

View all positions for OUP Management

Top funds holding Ikena Oncology

Atlas Venture Life Science Advisors
BVF
OrbiMed Advisors
Omega Fund Management
Blue Owl Capital Holdings
Vanguard Group
Artal Group
NEA Management Company
Laurion Capital Management
Barclays
Citadel Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Jacobs Levy Equity Management
Two Sigma Investments

View all funds holding Ikena Oncology